INVO Fertility, Inc. (IVF)
IVF Stock Price Chart
Explore INVO Fertility, Inc. interactive price chart. Choose custom timeframes to analyze IVF price movements and trends.
IVF Company Profile
Discover essential business fundamentals and corporate details for INVO Fertility, Inc. (IVF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
2 Nov 2020
Employees
30.00
Website
https://www.invobioscience.comCEO
Steven Shum
Description
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
IVF Financial Timeline
Browse a chronological timeline of INVO Fertility, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.70, while revenue estimate is $2.40m.
Earnings released on 22 Jun 2026
EPS came in at -$3.38 falling short of the estimated -$2.75 by -22.91%, while revenue for the quarter reached $1.93m , meeting expectations.
Earnings released on 2 Jun 2026
EPS came in at $2.96 surpassing the estimated -$2.75 by +207.64%, while revenue for the quarter reached $1.58m , missing expectations by -17.94%.
Stock split effective on 27 Mar 2026
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 28 Nov 2025
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Nov 2025
EPS came in at -$30.80 surpassing the estimated -$57.60 by +46.53%, while revenue for the quarter reached $1.76m , missing expectations by -3.19%.
Earnings released on 14 Aug 2025
EPS came in at -$3.18 falling short of the estimated -$0.72 by -341.67%, while revenue for the quarter reached $1.86m , beating expectations by +11.24%.
Stock split effective on 21 Jul 2025
Shares were split 1 : 3 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 May 2025
EPS came in at -$15.04 falling short of the estimated -$0.72 by -1.99k%, while revenue for the quarter reached $1.64m , beating expectations by +1.97%.
Stock split effective on 18 Mar 2025
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2024
EPS came in at -$11.71 , while revenue for the quarter reached $1.69m .
Earnings released on 19 Nov 2024
EPS came in at -$5.04 surpassing the estimated -$129.60 by +96.11%, while revenue for the quarter reached $1.43m , missing expectations by -64.49%.
Earnings released on 14 Aug 2024
EPS came in at -$8.93 falling short of the estimated -$2.02 by -342.86%, while revenue for the quarter reached $1.84m , missing expectations by -43.90%.
Earnings released on 16 Apr 2024
EPS came in at -$35.88 falling short of the estimated -$12.53 by -186.44%, while revenue for the quarter reached $3.52m , beating expectations by +82.39%.
Earnings released on 31 Dec 2023
EPS came in at -$0.80 , while revenue for the quarter reached $1.38m .
Earnings released on 13 Nov 2023
EPS came in at -$6.74 surpassing the estimated -$11.88 by +43.25%, while revenue for the quarter reached $1.35m , beating expectations by +35.68%.
Earnings released on 14 Aug 2023
EPS came in at -$36.72 surpassing the estimated -$50.40 by +27.14%, while revenue for the quarter reached $712.43k , beating expectations by +58.32%.
Stock split effective on 28 Jul 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$48.00 falling short of the estimated -$38.40 by -25.00%, while revenue for the quarter reached $646.71k , beating expectations by +72.92%.
Earnings released on 14 Nov 2022
EPS came in at -$4.20 falling short of the estimated -$2.40 by -75.00%, while revenue for the quarter reached $450.13k , beating expectations by +125.07%.
IVF Stock Performance
Access detailed IVF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
